Westpac Banking Corp cut its position in shares of Clorox Company (The) (NYSE:CLX) by 86.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,901 shares of the company’s stock after selling 48,400 shares during the quarter. Westpac Banking Corp’s holdings in Clorox Company (The) were worth $1,053,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in CLX. Nationwide Fund Advisors lifted its stake in Clorox Company (The) by 2.1% during the first quarter. Nationwide Fund Advisors now owns 36,264 shares of the company’s stock worth $4,889,000 after purchasing an additional 751 shares during the last quarter. Grandfield & Dodd LLC bought a new stake in Clorox Company (The) in the first quarter valued at $210,000. Jennison Associates LLC lifted its stake in Clorox Company (The) by 48.1% in the first quarter. Jennison Associates LLC now owns 311,636 shares of the company’s stock valued at $42,018,000 after buying an additional 101,227 shares during the last quarter. Advisor Partners LLC lifted its stake in Clorox Company (The) by 15.8% in the first quarter. Advisor Partners LLC now owns 2,745 shares of the company’s stock valued at $370,000 after buying an additional 375 shares during the last quarter. Finally, Advisory Services Network LLC bought a new stake in Clorox Company (The) in the first quarter valued at $363,000. Hedge funds and other institutional investors own 71.28% of the company’s stock.
In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP James E. Foster sold 9,861 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares in the company, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last three months, insiders sold 21,242 shares of company stock worth $2,944,449. Insiders own 0.74% of the company’s stock.
A number of equities research analysts have issued reports on CLX shares. BidaskClub cut Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price on the stock in a research note on Tuesday, July 4th. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Barclays PLC reiterated an “equal weight” rating and issued a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Clorox Company (The) presently has a consensus rating of “Hold” and an average target price of $129.05.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.themarketsdaily.com/2017/09/11/clorox-company-the-clx-shares-sold-by-westpac-banking-corp.html.
Clorox Company (NYSE CLX) opened at 134.04 on Monday. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The stock’s 50 day moving average price is $135.59 and its 200-day moving average price is $135.27. The firm has a market capitalization of $17.30 billion, a price-to-earnings ratio of 25.12 and a beta of 0.40.
Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.30 earnings per share. On average, equities research analysts anticipate that Clorox Company will post $5.66 earnings per share for the current fiscal year.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.